Near-Infrared Photoimmunotherapy Targeting Esophagogastric Junction Adenocarcinoma with Fully Human Anti-EpCAM Antibody

Puntos clave

• Photoimmunotherapy targeting adenocarcinoma shows significant effectiveness based on observed outcomes.
• The application of fully human anti-EpCAM antibody demonstrates promising tumor targeting ability during treatment.
• This approach utilizes near-infrared photoimmunotherapy as an innovative method for cancer treatment.
• Successful results may enable advancements in therapeutic strategies, particularly for esophagogastric junction adenocarcinoma.